ESC 365 - Dangers of polypharmacy: how to identify and how to limit the risk

EAPC Premium Access

Dangers of polypharmacy: how to identify and how to limit the risk

Session: Polypharmacy challenges in preventive cardiology

Topic: Pharmacotherapy

Speaker: Assistant Professor M. Fiuza (Lisbon, PT)

Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

About the speaker

Assistant Professor Maria Manuela Fiuza

CHULN and Faculty of medicine of the University of Lisbon, Lisbon (Portugal)

1 presentation

0 follower

2 more presentations in this session

Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting

Speaker: Doctor M. Antonopoulou (Rethymno, GR)

Case 2 - an elderly female patient with chronic kidney disease: polypharmacy in a secondary preventive setting

Speaker: Professor B. Rocca (Casamassima, IT)

Access the full session

Polypharmacy challenges in preventive cardiology

Speakers: Assistant Professor M. Fiuza, Doctor M. Antonopoulou, Professor B. Rocca

About the event

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources